Drugmaker Merck & Co. is buying Afferent Pharmaceuticals, a privately held biotechnology company developing a chronic cough medication.
North Carolina's largest healthcare system has kept medical costs high and suppressed competition by illegally imposing certain requirements on insurers with which it contracts, the U.S. Justice Department and state attorney general alleged in a lawsuit filed last week.
Drugmaker Genentech will pay the government $67 million to settle allegations that it oversold the effectiveness of one of its cancer drugs.
A Mississippi health system has agreed to pour $150 million into its pension system over the next four decades to settle class-action lawsuits that alleged it underfunded the plan.
U.S. Solicitor General Donald Verrilli—who defended the Affordable Care Act in several major Supreme Court cases—will step down as of June 24. His principal deputy, Ian Gershengorn, will replace him as acting solicitor general.
The former patients of a chain of New Mexico clinics that filed for bankruptcy are having trouble accessing their medical records, and legal experts say consumers may have little recourse.
The U.S. Supreme Court could announce as early as Monday whether it will take a case dealing with a Washington state regulation that says pharmacies can't refuse to fill prescriptions because of their owners' religious beliefs.
The number of health insurers suing the Obama administration over the Affordable Care Act’s hampered risk-corridor program continues to grow.
U.S. Solicitor General Donald Verrilli—who defended the Affordable Care Act in several major Supreme Court cases—will step down at the end of this month, the Justice Department said Thursday.
The Justice Department is siding with a legal argument by a fired Veterans Affairs Department official at the center of a nationwide scandal over long wait times for veterans seeking medical care and secret lists covering up the delays.
The investigation was groundbreaking in many respects, and providers will likely feel its effects for years to come—in ways that are both potentially positive and negative for the hospital community.
The federal government has now thrown its weight behind long-circulated allegations that part of Prime Healthcare Services' turnaround strategy is to drive up revenue by leaning hard on doctors to admit more patients. But that may not stop the chain from snapping up more troubled hospitals.